Cellectis S.A. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Cellectis S.A., a foreign private issuer headquartered in Paris, France, on August 6, 2019. The filing serves to distribute a press release dated August 6, 2019, to U.S. investors pursuant to Rule 13a-16 of the Securities Exchange Act of 1934.
Financial Metrics
The provided filing text contains only the cover page and exhibit index. It does not include the content of the referenced press release or any financial statements. Consequently, no data is available regarding revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The filing text does not provide specific details on material changes versus prior periods. The document solely references the existence of a press release without summarizing its contents.
Guidance, Outlook, and Risks
Management commentary, guidance, outlook, risks, contingencies, and unusual items are not described in the provided text. The filing acts as a vehicle to deliver the press release (Exhibit 99.1) but does not contain the substance of that release.
Key Facts for Investor Verification
- The filing is a procedural Form 6-K referencing a press release dated August 6, 2019.
- The actual content of the press release is not included in the provided text.
- Investors must locate and review Exhibit 99.1 (the press release) to obtain specific corporate updates or financial data.
- The registrant is identified as Cellectis S.A., with André Choulika signing as Chief Executive Officer.